Glyformin (Metformin Hydrochloride)

Glyformin is indicated for the management of elevated blood glucose levels in adults diagnosed with type 2 diabetes mellitus, typically as part of a comprehensive treatment plan that includes diet and exercise.

• As monotherapy in patients whose glycemic control is not achieved with diet and exercise alone.
• In combination with other oral antidiabetic agents when additional glucose lowering is needed.
• As an adjunct to insulin therapy to reduce insulin dose requirements.
• For patients with overweight or obesity where improved insulin sensitivity is beneficial.

Like other metformin products, Glyformin may cause a range of adverse effects that vary in frequency and severity, and may affect different organ systems.

Common

• Gastrointestinal upset such as nausea, abdominal discomfort, or diarrhea.
• Metallic taste in the mouth.
• Decreased appetite.
• Mild headache.
• Mild dizziness or light‑headedness.
• Altered taste sensation.
• Transient insomnia.

Serious

• Lactic acidosis, a rare but life‑threatening metabolic complication.
• Severe skin reactions including Stevens‑Johnson syndrome.
• Hepatic dysfunction manifested by jaundice or elevated liver enzymes.
• Persistent vomiting leading to dehydration.
• Acute renal failure in patients with pre‑existing kidney disease.
• Severe hypoglycemia when combined with insulin or sulfonylureas.
• Cardiovascular events such as arrhythmia in susceptible patients.

Before initiating Glyformin, healthcare providers should evaluate several clinical factors to minimize risk and ensure appropriate use.

• Assess renal function; metformin is contraindicated in severe renal impairment.
• Review hepatic status, as liver disease may increase lactic acidosis risk.
• Evaluate for conditions that predispose to hypoxia (e.g., heart failure, recent myocardial infarction).
• Consider age and frailty, especially in elderly patients.
• Advise patients to temporarily discontinue the drug before radiologic procedures using iodinated contrast.
• Monitor vitamin B12 levels during long‑term therapy.
• Ensure adequate hydration, particularly during illness or fasting.

Glyformin can interact with other medicines, affecting its efficacy or safety profile.

Avoid

• Concomitant use with other biguanides or high‑dose metformin formulations.
• Strong inhibitors of renal tubular secretion such as cimetidine or trimethoprim.
• Excessive alcohol consumption, which may increase the risk of lactic acidosis.
• Concurrent use with potent nephrotoxic agents such as aminoglycosides.

Use with caution

• Iodinated contrast agents; hold Glyformin before and after the procedure.
• Certain diuretics (e.g., thiazides) that may affect renal function.
• Medications that may cause hypoglycemia (e.g., sulfonylureas, insulin) requiring dose adjustments.
• Beta‑blockers may mask hypoglycemia symptoms; monitor blood glucose closely.